# GSK3640254 First Time in Human (FTIH) Study in Healthy Volunteers

> **NCT03231943** · PHASE1 · COMPLETED · sponsor: **ViiV Healthcare** · enrollment: 78 (actual)

## Conditions studied

- Infection, Human Immunodeficiency Virus
- HIV Infections

## Interventions

- **DRUG:** GSK3640254
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT03231943
- **Lead sponsor:** ViiV Healthcare
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2017-09-19
- **Primary completion:** 2018-09-09
- **Final completion:** 2018-09-09
- **Target enrollment:** 78 (ACTUAL)
- **Last updated:** 2021-06-10

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03231943

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03231943, "GSK3640254 First Time in Human (FTIH) Study in Healthy Volunteers". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT03231943. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*